ICU Ed and Todd-Cast Old/Old/Old: VASST, VANISH, ATHOS-3
Feb 27, 2024
In this episode, the hosts dive into the world of vasopressors, focusing on vasopressin and angiotensin-2 in trials like VASST, VANISH, and ATHOS-3. They discuss the challenges of managing blood pressure, trial outcomes, and implications for clinical practice. The chapter also explores ethical debates, treatment strategies, and the efficacy of different pressors in critical care settings.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9
Introduction
00:00 • 2min
Exploring Vasopressin and ARDS Management
01:33 • 14min
Exploring the Use of Vasopressin in Clinical Practice
15:50 • 16min
Analyzing the 'vanish' Study and Treatment Protocols
31:48 • 3min
Debate on Penalizing Patients for Death in Outcome Assessments
34:20 • 2min
Challenges and Outcomes of a Clinical Trial Investigating Vasopressin and Norepinephrine
36:18 • 9min
Analyzing the Acronym 'Eight Those Three' for High Output Shock Treatment Study
45:03 • 2min
Exploring the Effects of Angiotensin on Blood Pressure Regulation
46:55 • 2min
Efficacy and Considerations of Angiotensin 2 in Critical Care
48:41 • 15min